Periodic Reporting for period 1 - uHeart (A beating Heart-on-Chip for pre-clinical early detection of drugs cardiac safety)

The cost to develop a new single drug is estimated around 2.8B$, and the average time to market is 12 years; both trends are continuously growing. Less than 1% of the initially investigated candidate drugs reach the market, while the others fail along t he way. The further in...